<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01240772</url>
  </required_header>
  <id_info>
    <org_study_id>STIC/10/01</org_study_id>
    <secondary_id>IDRCB 2010-A00642-37</secondary_id>
    <nct_id>NCT01240772</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Trial Comparing Transanal Doppler-guided Arterial Ligation With Mucopexy and Stapled Haemorrhoidopexy</brief_title>
  <acronym>LIGALONGO</acronym>
  <official_title>Cost-effectiveness of New Surgical Treatments for Haemorrhoidal Disease - Randomized Controlled Trial Comparing Transanal Doppler-guided Arterial Ligation With Mucopexy and Stapled Haemorrhoidopexy (Longo's Technique)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multicentre RCT aims to compare two surgical treatments of haemorrhoidal disease:
      doppler-guided arterial ligation with mucopexy (DGALM) and stapled haemorrhoidopexy according
      to Longo (SH). The hypothesis of the trial is that the DGALM is at a lesser risk and is more
      cost-effective than SH. With a large number of patients managed in more than 20 centres, we
      aim to demonstrate that DGALM has a lower morbidity than SH when treating haemorrhoidal
      disease. At a lower postoperative risk and a lower risk of sequelae, the DGALM would
      demonstrate to be cost-effective for health care system and attractive for patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morbidity at 60 days postoperatively of the 2 techniques</measure>
    <time_frame>60-90 days</time_frame>
    <description>Morbidity at 60 days postoperatively of the 2 techniques, the morbidity being defined as &quot; the sum of adverse events that occurred during or after the procedure for a period of 2 months&quot;.Primary outcome measure is &quot;the percentage of patients with complication, whatever the number of complications per patient and the grade of complication according to the Clavien-Dindo classification&quot;.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness of the 2 procedures</measure>
    <time_frame>12 months</time_frame>
    <description>global cost of the treatment, length of stay, sick leave, cost of complications and sequelae management</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success rate at 1 year of each procedure regarding the control of haemorrhoids symptoms</measure>
    <time_frame>1 year</time_frame>
    <description>Efficiency regarding the cure of haemorrhoidal symptoms that led to surgery
Pain
Persisting or recurring symptoms of haemorrhoidal disease
Prolapse
Bleeding
Haemorrhoidal thrombose
Occurrence of new anal symptoms / surgical sequelae
Incontinence
Soiling
Pruritus
Anal stenosis
Constipation
Fissure
Other rare complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of anatomical or functional sequelae</measure>
    <time_frame>1 year</time_frame>
    <description>Assessment will be done according to Grade II vs Grade III patients as well as patients without and with antithrombotic treatments</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">407</enrollment>
  <condition>Symptomatic Haemorrhoidal Disease Requiring Surgical Management</condition>
  <arm_group>
    <arm_group_label>DGALM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>doppler-guided arterial ligation with mucopexy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>stapled haemorrhoidopexy according to Longo</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>doppler-guided arterial ligation with mucopexy</intervention_name>
    <description>doppler-guided arterial ligation with mucopexy</description>
    <arm_group_label>DGALM</arm_group_label>
    <other_name>THD</other_name>
    <other_name>AMI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>stapled haemorrhoidopexy according to Longo</intervention_name>
    <description>stapled haemorrhoidopexy according to Longo</description>
    <arm_group_label>SH</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient (male or female) 18 - 75 y.o

          -  Suffering from symptomatic grade II or III haemorrhoidal disease (bleeding and/or
             prolapse)

          -  requiring surgery

        Exclusion Criteria:

          -  Acute complication of haemorrhoidal disease

          -  History of anal surgery for haemorrhoids

          -  Congenital or acquirred anal stenosis

          -  Anal fissure or perianal abcess

          -  Inflammatory bowel disease

          -  Colon or rectal cancerv History of rectal or sigmoid resection

          -  Rectal prolapse

          -  Portal vein hypertension

          -  Haemophylia

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Angers University Hospital</name>
      <address>
        <city>Angers</city>
        <zip>49033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grenoble University Hospital</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>La Roche/Yon Hospital</name>
      <address>
        <city>La Roche/Yon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lille University Hospital &quot;Claude Huriez&quot;</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marseille University Hospital &quot;Hôpital Nord&quot;</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marseille University Hospital &quot;La Timone&quot;</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Niort Hospital</name>
      <address>
        <city>Niort</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nîmes University Hospital</name>
      <address>
        <city>Nîmes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polyclinic H. MALARTIC</name>
      <address>
        <city>Ollioules</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Institut Mutualiste Montsouris&quot;</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital St Joseph</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Poissy / Saint-Germain en Laye Hospital</name>
      <address>
        <city>Poissy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rennes University Hospital</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint-Etienne University Hospital</name>
      <address>
        <city>Saint-Etienne</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Pôle Hospitalier Mutualiste&quot;</name>
      <address>
        <city>Saint-Nazaire</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Strasbourg University Hospital</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foch Hospital</name>
      <address>
        <city>Suresnes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Talence Bagatelle Hospital</name>
      <address>
        <city>Talence</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toulouse University Hospital</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tours University Hospital</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vichy Hospital</name>
      <address>
        <city>Vichy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2010</study_first_submitted>
  <study_first_submitted_qc>November 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2010</study_first_posted>
  <last_update_submitted>August 22, 2014</last_update_submitted>
  <last_update_submitted_qc>August 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Haemorrhoids, Surgery, Cost-effectiveness, Morbidity, Risk assessment,RCT, Stapled haemorrhoidopexy, Doppler-guided, Haemorrhoidal artery ligation, Outcome</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

